Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases

Tacrolimus is an immunosuppressant used to treat a large variety of inflammatory or immunity-mediated ophthalmic diseases. However, there are currently no commercial industrial forms available that can provide relief to patients. Various ophthalmic formulations have been reported in the literature,...

Full description

Saved in:
Bibliographic Details
Main Authors: Marion Barrieu (Author), Philip Chennell (Author), Mouloud Yessaad (Author), Yassine Bouattour (Author), Mathieu Wasiak (Author), Mireille Jouannet (Author), Yoann Le Basle (Author), Valérie Sautou (Author)
Format: Book
Published: MDPI AG, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available